Videos
Experts in breast oncology review 4 clinical cases and discuss individualized treatment approaches for each patient.
Kerry Rogers, MD, discusses an important unmet need in patients with hairy cell leukemia.
Tatyana Feldman, MD, discusses the design and efficacy of the ECHELON-1 trial investigating brentuximab vedotin with chemotherapy in patients with stage III or IV Hodgkin lymphoma after a 3-year update.
Alexey V. Danilov, MD, PhD, discusses a treatment regimen of venetoclax plus rituximab used for patients with chronic lymphocytic leukemia the 2019 American Society of Hematology Annual Meeting.
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
Roxadustat Granted Orphan Drug Designation for Myelodysplastic Syndromes
2
Dr Mayer on Giredestrant's Success in Early Breast Cancer
3
Sacituzumab Govitecan: Elevating Quality of Life in First-Line TNBC
4
PLT012 Receives IND Clearance from FDA for Solid Tumors
5